{
    "medicine_id": "ee9f25edc3f499570cf60ad5e8eab802d01bc2cf",
    "platform_id": "DB00910",
    "metadata": {
        "name": "Paricalcitol 1 ug 1 Capsule liquid filled",
        "composition": "1 ug 1 Paricalcitol",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment of secondary hyperparathyroidism associated with chronic kidney disease CKD Stage 3 and 4",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Secondary hyperparathyroidism is characterized by an elevation in parathyroid hormone PTH associated with inadequate levels of active vitamin D hormone The source of vitamin D in the body is from synthesis in the skin and from dietary intake Vitamin D requires two sequential hydroxylations in the liver and the kidney to bind to and to activate the vitamin D receptor VDR The endogenous VDR activator calcitriol 1 25 OH 2 D3 is a hormone that binds to VDRs that are present in the parathyroid gland intestine kidney and bone to maintain parathyroid function and calcium and phosphorus homeostasis and to VDRs found in many other tissues including prostate endothelium and immune cells VDR activation is essential for the proper formation and maintenance of normal bone In the diseased kidney the activation of vitamin D is diminished resulting in a rise of PTH subsequently leading to secondary hyperparathyroidism and disturbances in the calcium and phosphorus homeostasis 1 Decreased levels of 1 25 OH 2 D3 have been observed in early stages of chronic kidney disease The decreased levels of 1 25 OH 2 D3 and resultant elevated PTH levels both of which often precede abnormalities in serum calcium and phosphorus affect bone turnover rate and may result in renal osteodystrophy An in vitro study indicates that paricalcitol is not an inhibitor of CYP1A2 CYP2A6 CYP2B6 CYP2C8 CYP2C9 CYP2C19 CYP2D6 CYP2E1 or CYP3A at concentrations up to 50 nM 21 ng mL",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06723",
                        "description": "The serum concentration of Aluminum hydroxide can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01406",
                        "description": "Danazol may increase the hypercalcemic activities of Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "The serum concentration of Sucralfate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The serum concentration of Magnesium sulfate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The serum concentration of Magnesium salicylate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "The serum concentration of Magaldrate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The serum concentration of Magnesium hydroxide can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The serum concentration of Magnesium trisilicate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "The serum concentration of Magnesium chloride can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The serum concentration of Magnesium carbonate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB09511",
                        "description": "The serum concentration of Talc can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The serum concentration of Magnesium citrate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "The serum concentration of Hydrotalcite can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13359",
                        "description": "The serum concentration of Magnesium aspartate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The serum concentration of Magnesium peroxide can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13749",
                        "description": "The serum concentration of Magnesium gluconate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13786",
                        "description": "The serum concentration of Magnesium orotate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB14514",
                        "description": "The serum concentration of Magnesium levulinate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB14515",
                        "description": "The serum concentration of Magnesium lactate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01083",
                        "description": "Orlistat can cause a decrease in the absorption of Paricalcitol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Digoxin"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Acetyldigitoxin"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Deslanoside"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Ouabain"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Oleandrin"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Cymarin"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Proscillaridin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Lanatoside C"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Gitoformate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Peruvoside"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Digitoxin"
                    },
                    {
                        "drugbank-id": "DB11057",
                        "description": "Mineral oil can cause a decrease in the absorption of Paricalcitol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The risk or severity of hypercalcemia can be increased when Methyclothiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The risk or severity of hypercalcemia can be increased when Bendroflumethiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The risk or severity of hypercalcemia can be increased when Benzthiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The risk or severity of hypercalcemia can be increased when Cyclothiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The risk or severity of hypercalcemia can be increased when Hydroflumethiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The risk or severity of hypercalcemia can be increased when Chlorothiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of hypercalcemia can be increased when Hydrochlorothiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The risk or severity of hypercalcemia can be increased when Trichlormethiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The risk or severity of hypercalcemia can be increased when Polythiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The risk or severity of hypercalcemia can be increased when Mebutizide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The risk or severity of hypercalcemia can be increased when Cyclopenthiazide is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00136",
                        "description": "The risk or severity of adverse effects can be increased when Calcitriol is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00146",
                        "description": "The risk or severity of adverse effects can be increased when Calcifediol is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00153",
                        "description": "The risk or severity of adverse effects can be increased when Ergocalciferol is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The risk or severity of adverse effects can be increased when Cholecalciferol is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01070",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Dihydrotachysterol"
                    },
                    {
                        "drugbank-id": "DB01436",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Alfacalcidol"
                    },
                    {
                        "drugbank-id": "DB04258",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Seocalcitol"
                    },
                    {
                        "drugbank-id": "DB04796",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Inecalcitol"
                    },
                    {
                        "drugbank-id": "DB04891",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Becocalcidiol"
                    },
                    {
                        "drugbank-id": "DB05295",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Eldecalcitol"
                    },
                    {
                        "drugbank-id": "DB06117",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with 1alpha 24S Dihydroxyvitamin D2"
                    },
                    {
                        "drugbank-id": "DB06194",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Elocalcitol"
                    },
                    {
                        "drugbank-id": "DB06272",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Maxacalcitol"
                    },
                    {
                        "drugbank-id": "DB06410",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Doxercalciferol"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Vitamin D"
                    },
                    {
                        "drugbank-id": "DB13097",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with 1alpha Hydroxyvitamin D5"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The risk or severity of adverse effects can be increased when Calcium acetate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00326",
                        "description": "The risk or severity of adverse effects can be increased when Calcium glucoheptonate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The risk or severity of adverse effects can be increased when Calcium chloride is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01373",
                        "description": "The risk or severity of adverse effects can be increased when Calcium is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The risk or severity of adverse effects can be increased when Calcium carbonate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The risk or severity of adverse effects can be increased when Calcium citrate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The risk or severity of adverse effects can be increased when Calcium gluconate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The risk or severity of adverse effects can be increased when Calcium Phosphate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13142",
                        "description": "The risk or severity of adverse effects can be increased when Calcium glubionate anhydrous is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13231",
                        "description": "The risk or severity of adverse effects can be increased when Calcium lactate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13365",
                        "description": "The risk or severity of adverse effects can be increased when Calcium lactate gluconate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13590",
                        "description": "The risk or severity of adverse effects can be increased when Calcium pangamate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB13800",
                        "description": "The risk or severity of adverse effects can be increased when Calcium levulinate is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The risk or severity of adverse effects can be increased when Calcium cation is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The risk or severity of adverse effects can be increased when Calcium polycarbophil is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB00375",
                        "description": "The serum concentration of Paricalcitol can be decreased when it is combined with Colestipol"
                    },
                    {
                        "drugbank-id": "DB00658",
                        "description": "The serum concentration of Paricalcitol can be decreased when it is combined with Sevelamer"
                    },
                    {
                        "drugbank-id": "DB00930",
                        "description": "The serum concentration of Paricalcitol can be decreased when it is combined with Colesevelam"
                    },
                    {
                        "drugbank-id": "DB01432",
                        "description": "The serum concentration of Paricalcitol can be decreased when it is combined with Cholestyramine"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluocortin"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluperolone"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Flunisolide"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluocinolone acetonide"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Prednisone"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fludrocortisone"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Trilostane"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Aldosterone"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone cypionate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Cortisone"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Desoximetasone"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB15566",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Prednisolone acetate"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluorometholone"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "The risk or severity of hypokalemia can be increased when Paricalcitol is combined with Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "The risk or severity of hypokalemia can be increased when Paricalcitol is combined with Metolazone"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of hypokalemia can be increased when Paricalcitol is combined with Indapamide"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "The risk or severity of hypokalemia can be increased when Paricalcitol is combined with Quinethazone"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "The risk or severity of hypokalemia can be increased when Paricalcitol is combined with Epitizide"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Paricalcitol can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Paricalcitol can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Paricalcitol can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The metabolism of Paricalcitol can be decreased when combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The metabolism of Paricalcitol can be decreased when combined with Idelalisib"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The risk or severity of adverse effects can be increased when Paricalcitol is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Paricalcitol can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Paricalcitol can be decreased when it is combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Paricalcitol can be decreased when it is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Paricalcitol can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Paricalcitol can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Paricalcitol can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}